Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Boundless Bio, Inc. publishes a filing, an earnings call transcript or a press release.

Get BOLD alerts

About Jennifer Lew

Jennifer Lew is recorded as Board Member at Boundless Bio, Inc. (BOLD) and CFO at Annexon, Inc. (ANNX). The newest filing on record that lists Jennifer Lew as Board Member at Boundless Bio, Inc. (BOLD) is dated April 28, 2026. The newest filing on record that lists Jennifer Lew as CFO at Annexon, Inc. (ANNX) is dated April 27, 2026. The proxy statement of Annexon, Inc. reports total compensation of $1,341,274 for Jennifer Lew in fiscal 2025, including a base salary of $495,817. Disclosed compensation is on record for 3 fiscal years. Annexon, Inc. is classified in the Biotechnology industry within the Healthcare sector. Boundless Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Annexon, Inc. includes Douglas Love (CEO and Board Member), Ted Yednock, Ph.D. (CIO), Bettina M. Cockroft (Board Member) and 4 others.

Affiliation history

Company network

Leadership on record at Annexon, Inc.

Leadership on record at Boundless Bio, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Annexon, Inc. (ANNX) $495,817 $1,341,274
2022 Annexon, Inc. (ANNX) $435,325 $1,440,415
2021 Annexon, Inc. (ANNX) $404,567 $3,127,757

Recent activity

No call appearances or filed executive changes recorded yet.